Regulation, Compliance and Risk
Survive... and thrive in today's hyper-regulatory environment
Informed by over 40 years of expertise and study of the healthcare compliance landscape, this G2 research portfolio gives diagnostic labs and pathology groups clear guidance for operating at reduced regulatory risk.
Choose from the titles below for details or contact Jonathon Wentworth-Ping, Director, at +1.973.718.4703 for more information.
| Creating a Value-Driven Laboratory: Opportunities in the New Marketplace |
| How to Build a Molecular Testing Laboratory: Key Strategic & Operational Considerations |
| Sales Compensation in the Laboratory Industry:
Incentives, Plans and Strategies |
| Health Care Market Reforms: Implications and Prescriptions for Laboratories |
| Business Strategies for Molecular Diagnostics in the Clinical Laboratory, 2nd Edition |
| Business Strategies for Laboratory Outreach Programs, 3rd Edition |
| Guide to Laboratory Sales & Marketing |
| Medicare Payment and Policy Guide for Laboratory and Pathology Services 2012 |
| Directory of Laboratory Outreach Programs 2009 |
| CLIA Compliance: The Essential Reference for the Clinical Laboratory, 3rd Edition |
| Guide to Integrated Diagnostics: Where Digital Pathology, Digital Radiology and Molecular Diagnostics Meet |
| Survival Guide to Negotiating Managed Care Contracts |
| Business Strategies for Anatomic Pathology, Second Edition |